IHS Chemical Week

Regions :: India/Pakistan

European regulatory authorities to reinstate GMP certificate for Ranbaxy’s API plant at Toansa

8:03 AM MDT | June 5, 2014 | Deepti Ramesh

After assessing of Ranbaxy Laboratories' (Gurgaon, India) active pharmaceutical ingredient (API) manufacturing facility at Toansa, India, European regulatory authorities say the company has instituted corrective measures and are satisfied that the measures are sufficient to ensure GMP-compliant manufacture of products at the site, the European Medicines Agency (EMA; London) announced today. As a consequence, EU authorities will reinstate the GMP certificate that was suspended in January, EMA says. The assessment follows a US FDA inspection, which...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa